Change in hepatitis B virus large surface antigen variant prevalence 13 years after implementation of a universal vaccination program in China

Journal of Virology

Volumn 87, Issue 22, 2013, Pages 12196-12206

  Bian, Tao ^a,b   Yan, Hongxia ^a,c   Shen, Liping ^a   Wang, Feng ^a   Zhang, Shuang ^a   Cao, Yanqiang ^d   Zhang, Shuo ^a   Zhang, Yong ^a   Bi, Shengli ^a  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b University of North Carolina   (United States)

^c Beijing Haidian District Bureau of Quality and Technical Supervision   (China)

^d Hebei Entry Exit Inspection and Quarantine Bureau   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR; ENTECAVIR; FAMCICLOVIR; HEPATITIS B SURFACE ANTIGEN; LAMIVUDINE; MEMBRANE PROTEIN; TENOFOVIR; HEPATITIS B VACCINE; VIRUS DNA;

ADOLESCENT; ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; CHILD; CHINA; CONTROLLED STUDY; DELETION MUTANT; FEMALE; GENE; GENE AMPLIFICATION; GENE SEQUENCE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LBH GENE; MAJOR CLINICAL STUDY; MALE; MUTATION RATE; NUCLEOTIDE SEQUENCE; PREVALENCE; PRIORITY JOURNAL; PROMOTER REGION; SCHOOL CHILD; START CODON; VACCINATION; AGE; COMPARATIVE STUDY; GENETICS; GENOTYPE; INFANT; MIDDLE AGED; MUTATION; PRESCHOOL CHILD; VERY ELDERLY; YOUNG ADULT;

HEPATITIS B VIRUS;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CHINA; DNA, VIRAL; FEMALE; GENOTYPE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; INFANT; MALE; MIDDLE AGED; MUTATION; PREVALENCE; SEROEPIDEMIOLOGIC STUDIES; VACCINATION; YOUNG ADULT;

EID: 84886257634     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02127-13     Document Type: Article

References (33)

1. Ganem D, Prince AM. 2004. Hepatitis B virus infection-natural history and clinical consequences. N. Engl. J. Med. 350:1118-1129.
2. Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. 2006. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J. Hepatol. 45:529-538.
3. Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, Zhang Y, Liu J, Gong X, Chen Y, Wang F, Zheng H, Guo J, Jia Z, Ma J, Wang H, Luo H, Li L, Jin S, Hadler SC, Wang Y. 2009. Evaluation of the impact of hepatitis B vaccination among children born during 1992-2005 in China. J. Infect. Dis. 200:39-47.
4. Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, Zhang Y, Liu J, Gong X, Chen Y, Wang F, Zheng H, Guo J, Jia Z, Ma J, Wang H, Luo H, Li L, Jin S, Hadler SC, Wang Y. 2009. Epidemiological serosurvey of hepatitis B in China-declining HBV prevalence due to hepatitis B vaccination. Vaccine 27:6550-6557.
5. Li RC, Yang JY, Gong J, Li YP, Huang ZN, Fang KX, Xu ZY, Liu CB, Zhao K, Zhuang H. 2004. Efficacy of hepatitis B vaccination on hepatitis B prevention and on hepatocellular carcinoma. Zhonghua Liu Xing Bing Xue Za Zhi 25:385-387. (In Chinese.)
6. Oon CJ, Lim GK, Ye Z, Goh KT, Tan KL, Yo SL, Hopes E, Harrison TJ, Zuckerman AJ. 1995. Molecular epidemiology of hepatitis B virus vaccine variants in Singapore. Vaccine 13:699-702.
7. Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP. 2006. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol. Rev. 28:112-125.
8. Carman WF, Zanetti AR, Karayiannis P, Waters J, Manzillo G, Tanzi E, Zuckerman AJ, Thomas HC. 1990. Vaccine-induced escape mutant of hepatitis B virus. Lancet 336:325-329.
9. Hsu HY, Chang MH, Liaw SH, Ni YH, Chen HL. 1999. Changes of hepatitis B surface antigen variants in carrier children before and after universal vaccination in Taiwan. Hepatology 30:1312-1317.
10. Chiou HL, Lee TS, Kuo J, Mau YC, Ho MS. 1997. Altered antigenicity of 'a' determinant variants of hepatitis B virus. J. Gen. Virol. 78(Part 10): 2639-2645.
11. Coleman PF. 2006. Detecting hepatitis B surface antigen mutants. Emerg. Infect. Dis. 12:198-203.
12. Zuckerman JN, Zuckerman AJ. 2003. Mutations of the surface protein of hepatitis B virus. Antiviral Res. 60:75-78.
13. Chen BF, Liu CJ, Jow GM, Chen PJ, Kao JH, Chen DS. 2006. High prevalence and mapping of pre-S deletion in hepatitis B virus carriers with progressive liver diseases. Gastroenterology 130:1153-1168.
14. Choi MS, Kim DY, Lee DH, Lee JH, Koh KC, Paik SW, Rhee JC, Yoo BC. 2007. Clinical significance of pre-S mutations in patients with genotype C hepatitis B virus infection. J. Viral Hepat. 14:161-168.
15. Wang HC, Huang W, Lai MD, Su IJ. 2006. Hepatitis B virus pre-S mutants, endoplasmic reticulum stress and hepatocarcinogenesis. Cancer Sci. 97:683-688.
16. Shen LP, Zhang Y, Wang F, Zhang S, Yang JY, Fang KX, Yu T, Wang XY, Zhang WY, Bi SL. 2011. Epidemiological changes in hepatitis B prevalence in an entire population after 20 years of the universal HBV vaccination programme. Epidemiol. Infect. 139:1159-1165.
17. Bian T, Zhang Y, Cao YQ, Wang JJ, Shen LP, Wang F, Wang Y, Bi SL. 2008. The analysis of hepatitis B virus genetic characterization and ratio of mutation in low-age group of HuNan. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 22:205-207. (In Chinese.)
18. Magnius LO, Norder H. 1995. Subtypes, genotypes and molecular epidemiology of the hepatitis B virus as reflected by sequence variability of the S-gene. Intervirology 38:24-34.
19. Kajiwara E, Tanaka Y, Ohashi T, Uchimura K, Sadoshima S, Kinjo M, Mizokami M. 2008. Hepatitis B caused by a hepatitis B surface antigen escape mutant. J. Gastroenterol. 43:243-247.
20. Purdy MA. 2007. Hepatitis B virus S gene escape mutants. Asian J. Transfus. Sci. 1:62-70.
21. Oon CJ, Chen WN. 1998. Current aspects of hepatitis B surface antigen mutants in Singapore. J. Viral Hepat. 5(Suppl 2):17-23.
22. Khan N, Guarnieri M, Ahn SH, Li J, Zhou Y, Bang G, Kim KH, Wands JR, Tong S. 2004. Modulation of hepatitis B virus secretion by naturally occurring mutations in the S gene. J. Virol. 78:3262-3270.
23. Hou J, Wang Z, Cheng J, Lin Y, Lau GK, Sun J, Zhou F, Waters J, Karayiannis P, Luo K. 2001. Prevalence of naturally occurring surface gene variants of hepatitis B virus in nonimmunized surface antigennegative Chinese carriers. Hepatology 34:1027-1034.
24. Pollicino T, Zanetti AR, Cacciola I, Petit MA, Smedile A, Campo S, Sagliocca L, Pasquali M, Tanzi E, Longo G, Raimondo G. 1997. Pre-S2 defective hepatitis B virus infection in patients with fulminant hepatitis. Hepatology 26:495-499.
25. Hsu HY, Chang MH, Ni YH, Chiang CL, Chen HL, Wu JF, Chen PJ. 2010. No increase in prevalence of hepatitis B surface antigen mutant in a population of children and adolescents who were fully covered by universal infant immunization. J. Infect. Dis. 201:1192-1200.
26. Cooreman MP, Leroux-Roels G, Paulij WP. 2001. Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen. J. Biomed. Sci. 8:237-247.
27. Lada O, Benhamou Y, Poynard T, Thibault V. 2006. Coexistence of hepatitis B surface antigen (HBs Ag) and anti-HBs antibodies in chronic hepatitis B virus carriers: influence of "a" determinant variants. J. Virol. 80:2968-2975.
28. Kim H, Lee SA, Kim DW, Lee SH, Kim BJ. 2013. Naturally occurring mutations in large surface genes related to occult infection of hepatitis B virus genotype C. PLoS One 8:e54486. doi:10.1371/journal.pone.0054486.
29. Ito K, Qin Y, Guarnieri M, Garcia T, Kwei K, Mizokami M, Zhang J, Li J, Wands JR, Tong S. 2010. Impairment of hepatitis B virus virion secretion by single-amino-acid substitutions in the small envelope protein and rescue by a novel glycosylation site. J. Virol. 84:12850-12861.
30. Mathet VL, Feld M, Espinola L, Sanchez DO, Ruiz V, Mando O, Carballal G, Quarleri JF, D'Mello F, Howard CR, Oubina JR. 2003. Hepatitis B virus S gene mutants in a patient with chronic active hepatitis with circulating anti-HBs antibodies. J. Med. Virol. 69:18-26.
31. Bian T, Shen LP, Wang F, Wang Y, Zhang LW, Zhang Y, Bi SL. 2008. Cloning of the full-length genome of A recombinant hepatitis B virus strain and phylogenetic analysis. Bing Du Xue Bao 24:255-259. (In Chinese.)
32. Zeng G, Wang Z, Wen S, Jiang J, Wang L, Cheng J, Tan D, Xiao F, Ma S, Li W, Luo K, Naoumov NV, Hou J. 2005. Geographic distribution, virologic and clinical characteristics of hepatitis B virus genotypes in China. J. Viral Hepat. 12:609-617.
33. Yao JL. 1996. Perinatal transmission of hepatitis B virus infection and vaccination in China. Gut 38(Suppl 2):S37-S38.